[go: up one dir, main page]

SK167797A3 - Alkalinizing potassium salt controlled release preparations - Google Patents

Alkalinizing potassium salt controlled release preparations Download PDF

Info

Publication number
SK167797A3
SK167797A3 SK1677-97A SK167797A SK167797A3 SK 167797 A3 SK167797 A3 SK 167797A3 SK 167797 A SK167797 A SK 167797A SK 167797 A3 SK167797 A3 SK 167797A3
Authority
SK
Slovakia
Prior art keywords
dosage form
crystals
amount
tablet dosage
coating
Prior art date
Application number
SK1677-97A
Other languages
English (en)
Slovak (sk)
Inventor
Herman Marder
Marc S Gross
Lawrence Kirschner
John J Steinke
Andrew D Kurtz
Poul Bertelsen
Nils G Hansen
Thyge B Hjorth
Original Assignee
Church & Dwight Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Church & Dwight Co Inc filed Critical Church & Dwight Co Inc
Publication of SK167797A3 publication Critical patent/SK167797A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1677-97A 1995-06-06 1996-06-06 Alkalinizing potassium salt controlled release preparations SK167797A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/472,693 US5674529A (en) 1995-06-06 1995-06-06 Alkalinizing potassium salt controlled release preparations
PCT/US1996/009016 WO1996039127A1 (en) 1995-06-06 1996-06-06 Alkalinizing potassium salt controlled release preparations

Publications (1)

Publication Number Publication Date
SK167797A3 true SK167797A3 (en) 1998-06-03

Family

ID=23876566

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1677-97A SK167797A3 (en) 1995-06-06 1996-06-06 Alkalinizing potassium salt controlled release preparations

Country Status (18)

Country Link
US (1) US5674529A (es)
EP (1) EP0840598A4 (es)
JP (1) JPH11506778A (es)
KR (1) KR19990022537A (es)
CN (1) CN1106837C (es)
AR (1) AR003131A1 (es)
AU (1) AU698784B2 (es)
BR (1) BR9608392A (es)
CA (1) CA2223281A1 (es)
CO (1) CO4700033A1 (es)
CZ (1) CZ288129B6 (es)
HU (1) HUP9900856A2 (es)
NO (1) NO312815B1 (es)
NZ (1) NZ310138A (es)
PL (1) PL323939A1 (es)
SK (1) SK167797A3 (es)
WO (1) WO1996039127A1 (es)
ZA (1) ZA964427B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP5014554B2 (ja) * 2000-06-14 2012-08-29 ジェイカムアグリ株式会社 被覆生物活性粒状物の製造方法
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
KR20050005437A (ko) 2002-04-09 2005-01-13 플라멜 테크놀로지스 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
WO2004091614A2 (en) * 2003-04-14 2004-10-28 Teva Pharmaceutical Industries Ltd. Stabilized amlodipine maleate formations
HUE038174T2 (hu) * 2007-10-12 2018-09-28 Ferring Int Center Sa Eljárás citromsavat, magnéziumoxidot, káliumbikarbonátot és nátriumpikoszulfátot tartalmazó gyógyszertermék elõállítására, ilyen eljárással elõállított szemcsés gyógyászati készítmény és köztitermékei
FR2967578B1 (fr) * 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
WO2025128724A1 (en) * 2023-12-12 2025-06-19 Arbert, Llc Coated inorganic salts and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US4863743A (en) * 1985-02-19 1989-09-05 Key Pharmaceuticals, Inc. Controlled release potassium chloride
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
DE68913311T2 (de) * 1988-10-21 1994-05-26 The Regents Of The University Of California, Oakland, Calif. Behandlung von Osteoporosis.
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5445805A (en) * 1993-05-06 1995-08-29 Church & Dwight Co., Inc. Large potassium bicarbonate crystals and process for the preparation thereof

Also Published As

Publication number Publication date
PL323939A1 (en) 1998-04-27
AR003131A1 (es) 1998-07-08
EP0840598A1 (en) 1998-05-13
NZ310138A (en) 1999-04-29
KR19990022537A (ko) 1999-03-25
AU6047396A (en) 1996-12-24
US5674529A (en) 1997-10-07
CN1106837C (zh) 2003-04-30
NO312815B1 (no) 2002-07-08
CZ288129B6 (cs) 2001-04-11
NO975567L (no) 1998-02-05
EP0840598A4 (en) 2001-08-29
HUP9900856A2 (hu) 1999-08-30
BR9608392A (pt) 1999-11-30
CA2223281A1 (en) 1996-12-12
CO4700033A1 (es) 1998-12-29
WO1996039127A1 (en) 1996-12-12
ZA964427B (en) 1997-02-24
AU698784B2 (en) 1998-11-05
CZ389297A3 (cs) 1998-06-17
NO975567D0 (no) 1997-12-03
JPH11506778A (ja) 1999-06-15
CN1187121A (zh) 1998-07-08

Similar Documents

Publication Publication Date Title
US4415547A (en) Sustained-release pharmaceutical tablet and process for preparation thereof
AU781707B2 (en) Oral pharmaceutical forms of administration with a delayed action
US5019398A (en) Pharmaceutical composition providing the sustained-release of valproic acid
US4716041A (en) Diffusion coated multiple-units dosage form
US5126145A (en) Controlled release tablet containing water soluble medicament
EP0605174B1 (en) Delayed, Sustained-release pharmaceutical preparation
AU623560B2 (en) Pharmaceutical granules and drug dosage units made therefrom
AU2009247921B2 (en) Solid oral form with dual release profile, containing multiparticulates
AU2002253039B2 (en) Tramadol-based medicament
JP2003508430A (ja) トラマドールサッカリナートを含有する徐放性投薬形
JP2000508673A (ja) イバンドロネートを含む経口薬理製剤
JPS63501080A (ja) 活性化合物の放出を制御する新規な製剤およびその製造法
PL211301B1 (pl) Tabletka wielowarstwowa dyspergowalna w ustach oraz sposób jej wytwarzania
RS50056B (sr) Kompozicije oksikodona sa kontrolisanim oslobađanjem
SK167797A3 (en) Alkalinizing potassium salt controlled release preparations
US20040076667A1 (en) Sustained release pharmaceutical composition containing metformin hydrochloride
CA2101697C (en) Controlled release potassium chloride tablet
WO2009069089A1 (en) Levetiracetam controlled release composition
FI95776B (fi) Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi
WO2003043610A2 (en) A process for manufacture of a sustained release composition containing microbe
US8980318B2 (en) Neramexane multiple unit dosage form
JPH06345649A (ja) イプサピロン薬剤組成物
RU2292877C2 (ru) Лекарственная ретард-форма, содержащая сахаринат трамадола
Menéndez A novel approach for the manufacturing of extended-release pellets